Skip to content

Preliminary validation of the Cognitive Affective Mindfulness Scale-Revised in cancer populations.

Stella Snyder, Ekin Secinti, Kelly Chinh, Wei Wu, Shelley A Johns, Catherine E Mosher

Psycho-oncology 2024 DOI: 10.1002/pon.6260 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional validation study Peer reviewed
Sample size 404
Population Patients with breast, gastrointestinal, lung, or prostate cancer
Duration One time point
Topics Meditation
Keywords Cancer Invariance testing Measurement Oncology Psychometrics
Citations 6
Key findings The 10-item CAMS-R demonstrated reasonable fit, excellent internal consistency, expected patterns of convergent and divergent validity, and measurement invariance across gender, cancer type, and cancer stage in a cancer patient sample.

Abstract

A brief, valid, and comprehensive measure of mindfulness is needed for cancer populations. This study examined the factor structure, internal consistency, construct validity, and measurement invariance of the 10-item Cognitive Affective Mindfulness Scale-Revised (CAMS-R) in patients with cancer. Patients with breast, gastrointestinal, lung, or prostate cancer (N = 404, 50% stage IV cancer, 51% women) were recruited from academic and public clinics in Indianapolis, IN. Patients completed the CAMS-R and other psychological measures at one time point. Confirmatory factor analysis (CFA) was used to examine the dimensionality of the CAMS-R. Internal consistency and construct validity were also assessed. Measurement invariance was examined for gender, cancer type, and cancer stage. CFA showed that the original CAMS-R structure with four first-order factors (attention, present focus, awareness, and acceptance) and one second-order factor (mindfulness) had a reasonable fit (RMSEA = 0.09, CFI = 0.95, SRMR = 0.04). Internal consistency was excellent (α = 0.90). The CAMS-R total score showed significant positive associations with several subscales of a widely used mindfulness questionnaire and self-compassion (rs = 0.61-0.66) and significant negative associations with anxiety, depressive symptoms, rumination, psychological inflexibility, and avoidant coping (rs = -0.35-0.58). Measurement invariance testing indicated that the CAMS-R was invariant across populations of varying genders, cancer types, and stages. Findings provide preliminary support for using the CAMS-R in cancer populations. Future research should assess the responsiveness of the CAMS-R to intervention.

Explore topics